Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Catabasis Pharmaceuticals Inc patents


Recent patent applications related to Catabasis Pharmaceuticals Inc. Catabasis Pharmaceuticals Inc is listed as an Agent/Assignee. Note: Catabasis Pharmaceuticals Inc may have other listings under different names/spellings. We're not affiliated with Catabasis Pharmaceuticals Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "C" | Catabasis Pharmaceuticals Inc-related inventors


Fatty acid niacin conjugates and their uses

The invention relates to fatty acid niacin conjugates; compositions comprising an effective amount of a fatty acid niacin conjugate; and methods for treating or preventing an metabolic disease comprising the administration of an effective amount of a fatty acid niacin conjugate.. . ... Catabasis Pharmaceuticals Inc

Fatty acid cysteine-based conjugates and their use in treating medical disorders

The invention relates to fatty acid cysteine-based conjugates, compositions comprising a fatty acid cysteine-based conjugates, and methods for using such conjugates and compositions to treat disease, such as a disease caused by dysregulation of autophagy or mitochondrial bioenergetics.. . ... Catabasis Pharmaceuticals Inc

Fatty acid cysteamine conjugates and their use as activators of autophagy

The invention relates to (i) 6-membered heteroaryl substituted fatty acid cystamine conjugates, compositions thereof, methods of treating diseases involving dysregulation of autophagy, such as cystic fibrosis, idiopathic pulmonary fibrosis (ipf), a neurodegenerative disease, inflammatory disease, liver disease, muscle disease, infection and immune disease with this compound, or (ii) a method of treating idiopathic pulmonary fibrosis, mitochondrial diseases, leigh syndrome, diabetes mellitus and deafness (dad), leber's hereditary optic neuropathy, neuropathy-ataxia-retinis pigmentosa and ptosis (narp), myoneurogenic gastrointestinal encephalopathy (mng1e), myoclonic epilepsy with ragged red fibers (merrf), or mitochondrial myopathy-encephalomy-opathy-lactic acidosis stroke like symptoms (melas), comprising administering to a patient the fatty acid cysteamine conjugate, (4z, 7z. 10z, 13z, 16z, 19z)—n-(2-mercaptoethyl) docosa-4,7,10,13,16,19-hexaenamide or (5z, 8z, 11z, 14z, 17z)—n-(2-mercaptoethyl) icosa-5,8,11,14,17-pentaenamide.. ... Catabasis Pharmaceuticals Inc

Fatty acid acetylated salicylates and their uses

The invention relates to fatty acid acetylated salicylate derivatives; compositions comprising an effective amount of a fatty acid acetylated salicylate derivative; and methods for treating or preventing an inflammatory disorder comprising the administration of an effective amount of a fatty acid acetylated salicylate derivative.. . ... Catabasis Pharmaceuticals Inc

Fatty acid amides, compositions and methods of use

The invention relates to fatty acid amides; compositions comprising an effective amount of a fatty acid amide; and methods for treating or preventing cancer, a metabolic disease or a neurodegenerative disease comprising the administration of an effective amount of a fatty acid amide.. . ... Catabasis Pharmaceuticals Inc








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Catabasis Pharmaceuticals Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Catabasis Pharmaceuticals Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###